Gene · 6891
Papers2,915
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,915
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation. | Leukemia | 2024 | 37919606 | PubTator, text mining | PubMed |
| CDK4/6 inhibitors induce breast cancer senescence with enhanced anti-tumor immunogenic properties compared with DNA-damaging agents. | Mol Oncol | 2024 | 37854019 | PubTator, text mining | PubMed |
| ATP-binding cassette transporters as possible targets for the intervention of neurodegenerative diseases. | Neural Regen Res | 2024 | 37843202 | PubTator, text mining | PubMed |
| Diffuse large B-cell lymphoma involving the central nervous system: biologic rationale for targeted therapy. | Haematologica | 2024 | 37706315 | PubTator, text mining | PubMed |
| Regulatory Variants on the Leukocyte Immunoglobulin-Like Receptor Gene Cluster are Associated with Crohn's Disease and Interact with Regulatory Variants for TAP2. | J Crohns Colitis | 2024 | 37523193 | PubTator, text mining | PubMed |
| EBV-microRNAs as Potential Biomarkers in EBV-related Fever: A Narrative Review. | Curr Mol Med | 2024 | 36411555 | PubTator, text mining | PubMed |
| Antigen-presenting B cells promote TCF-1+ PD1- stem-like CD8+ T-cell proliferation in glioblastoma. | Front Immunol | 2023 | 38268923 | PubTator, text mining | PubMed |
| Immune checkpoint inhibitors in breast cancer: development, mechanisms of resistance and potential management strategies. | Cancer Drug Resist | 2023 | 38263984 | PubTator, text mining | PubMed |
| Peripheral immune responses to filoviruses in a reservoir versus spillover hosts reveal transcriptional correlates of disease. | Front Immunol | 2023 | 38259437 | PubTator, text mining | PubMed |
| Chronic Thromboembolic Pulmonary Hypertension: A Review of the Multifaceted Pathobiology. | Biomedicines | 2023 | 38255153 | PubTator, text mining | PubMed |
| Integrated analysis of single-cell RNA-seq and chipset data unravels PANoptosis-related genes in sepsis. | Front Immunol | 2023 | 38239341 | PubTator, text mining | PubMed |
| NLRC5 overexpression in ovarian tumors remodels the tumor microenvironment and increases T-cell reactivity toward autologous tumor-associated antigens. | Front Immunol | 2023 | 38235131 | PubTator, text mining | PubMed |
| Mechanisms of T cell evasion by Epstein-Barr virus and implications for tumor survival. | Front Immunol | 2023 | 38179040 | PubTator, text mining | PubMed |
| Utilizing immunogenomic approaches to prioritize targetable neoantigens for personalized cancer immunotherapy. | Front Immunol | 2023 | 38149253 | PubTator, text mining | PubMed |
| Cranberry Proanthocyanidins Mitigate Reflux-Induced Transporter Dysregulation in an Esophageal Adenocarcinoma Model. | Pharmaceuticals (Basel) | 2023 | 38139823 | PubTator, text mining | PubMed |
| Knockouts of TNFRSF1A and TNFRSF1B Genes in K562 Cell Line Lead to Diverse Long-Lasting Responses to TNF-α. | Int J Mol Sci | 2023 | 38138998 | PubTator, text mining | PubMed |
| Molecular Characterization and Establishment of a Prognostic Model Based on Primary Immunodeficiency Features in Association with RNA Modifications in Triple-Negative Breast Cancer. | Genes (Basel) | 2023 | 38136994 | PubTator, text mining | PubMed |
| Comprehensive genomic profiling of breast cancers characterizes germline-somatic mutation interactions mediating therapeutic vulnerabilities. | Cell Discov | 2023 | 38114467 | PubTator, text mining | PubMed |
| An integrated workflow for quantitative analysis of the newly synthesized proteome. | Nat Commun | 2023 | 38086798 | PubTator, text mining | PubMed |
| Pre-treatment inflamed tumor immune microenvironment is associated with FOLFIRINOX response in pancreatic cancer. | Front Oncol | 2023 | 38074633 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6891/papers?page=6